PNC Financial Services Group’s Organogenesis Holdings ORGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-5
Closed -$26 5274
2025
Q4
$26 Hold
5
﹤0.01% 5124
2025
Q3
$21 Hold
5
﹤0.01% 5059
2025
Q2
$18 Buy
+5
New +$19 ﹤0.01% 4888
2024
Q1
Sell
-12
Closed -$49 4780
2023
Q4
$49 Buy
+12
New +$34 ﹤0.01% 4567
2023
Q2
Sell
-284
Closed -$605 4806
2023
Q1
$605 Sell
284
-2,495
-90% -$6.16K ﹤0.01% 4505
2022
Q4
$7.47K Sell
2,779
-3,979
-59% -$11.6K ﹤0.01% 3870
2022
Q3
$22K Buy
6,758
+2,180
+48% +$9.85K ﹤0.01% 3401
2022
Q2
$23K Buy
4,578
+1,211
+36% +$7.45K ﹤0.01% 3434
2022
Q1
$26K Sell
3,367
-1,213
-26% -$9.39K ﹤0.01% 3450
2021
Q4
$42K Buy
4,580
+2,258
+97% +$24K ﹤0.01% 3207
2021
Q3
$33K Buy
2,322
+327
+16% +$5.08K ﹤0.01% 3295
2021
Q2
$34K Buy
+1,995
New +$37.2K ﹤0.01% 3256

Other funds holding ORGO

PNC Financial Services Group's ORGO Position: Q1 2026 in Review

PNC Financial Services Group sold out of Organogenesis Holdings (ORGO) in Q1 2026, closing a stake of 5 shares — an estimated $26 sold.

PNC Financial Services Group first reported a position in ORGO in Q2 2021 and held it in 12 quarters. The position peaked at $42K in Q4 2021. 121 funds tracked by Wall St. Rank hold ORGO as of Q1 2026.

  • PNC Financial Services Group reported no remaining Organogenesis Holdings position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 5 Organogenesis Holdings shares in Q1 2026, an estimated $26.
  • PNC Financial Services Group first reported a position in Organogenesis Holdings in Q2 2021 and held it in 12 quarters.
  • PNC Financial Services Group's Organogenesis Holdings position peaked at $42K in Q4 2021.
  • 121 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.